Morgan Stanley’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,448
| Closed | -$13.7K | – | 8129 |
|
|
2025
Q1 | $13.7K | Sell |
1,448
-2,153
| -60% | -$20.3K | ﹤0.01% | 6706 |
|
|
2024
Q4 | $44.3K | Sell |
3,601
-1,443
| -29% | -$17.8K | ﹤0.01% | 6324 |
|
|
2024
Q3 | $75.4K | Sell |
5,044
-15,272
| -75% | -$228K | ﹤0.01% | 6100 |
|
|
2024
Q2 | $274K | Buy |
20,316
+1,063
| +6% | +$14.4K | ﹤0.01% | 5542 |
|
|
2024
Q1 | $320K | Sell |
19,253
-7,449
| -28% | -$124K | ﹤0.01% | 5526 |
|
|
2023
Q4 | $360K | Buy |
26,702
+23,190
| +660% | +$312K | ﹤0.01% | 5741 |
|
|
2023
Q3 | $38.5K | Hold |
3,512
| – | – | ﹤0.01% | 6274 |
|
|
2023
Q2 | $45.4K | Sell |
3,512
-525
| -13% | -$6.78K | ﹤0.01% | 6244 |
|
|
2023
Q1 | $48.4K | Sell |
4,037
-860
| -18% | -$10.3K | ﹤0.01% | 6299 |
|
|
2022
Q4 | $67.2K | Hold |
4,897
| – | – | ﹤0.01% | 6156 |
|
|
2022
Q3 | $72K | Hold |
4,897
| – | – | ﹤0.01% | 6233 |
|
|
2022
Q2 | $74K | Sell |
4,897
-845
| -15% | -$12.8K | ﹤0.01% | 6420 |
|
|
2022
Q1 | $104K | Buy |
5,742
+1,029
| +22% | +$18.6K | ﹤0.01% | 6278 |
|
|
2021
Q4 | $112K | Sell |
4,713
-1,667
| -26% | -$39.6K | ﹤0.01% | 6368 |
|
|
2021
Q3 | $193K | Hold |
6,380
| – | – | ﹤0.01% | 6018 |
|
|
2021
Q2 | $203K | Buy |
6,380
+2,434
| +62% | +$77.4K | ﹤0.01% | 6009 |
|
|
2021
Q1 | $118K | Buy |
3,946
+188
| +5% | +$5.62K | ﹤0.01% | 5921 |
|
|
2020
Q4 | $119K | Sell |
3,758
-897
| -19% | -$28.4K | ﹤0.01% | 5838 |
|
|
2020
Q3 | $127K | Buy |
4,655
+400
| +9% | +$10.9K | ﹤0.01% | 5316 |
|
|
2020
Q2 | $115K | Sell |
4,255
-6,350
| -60% | -$172K | ﹤0.01% | 5336 |
|
|
2020
Q1 | $207K | Sell |
10,605
-32,520
| -75% | -$635K | ﹤0.01% | 4848 |
|
|
2019
Q4 | $1.01M | Buy |
43,125
+2,659
| +7% | +$62.3K | ﹤0.01% | 4521 |
|
|
2019
Q3 | $759K | Buy |
40,466
+31,261
| +340% | +$586K | ﹤0.01% | 4462 |
|
|
2019
Q2 | $194K | Hold |
9,205
| – | – | ﹤0.01% | 5036 |
|
|
2019
Q1 | $193K | Sell |
9,205
-36,315
| -80% | -$761K | ﹤0.01% | 5083 |
|
|
2018
Q4 | $859K | Sell |
45,520
-44,634
| -50% | -$842K | ﹤0.01% | 4392 |
|
|
2018
Q3 | $2.24M | Sell |
90,154
-10,160
| -10% | -$252K | ﹤0.01% | 3916 |
|
|
2018
Q2 | $2.42M | Buy |
100,314
+93,845
| +1,451% | +$2.26M | ﹤0.01% | 3889 |
|
|
2018
Q1 | $188K | Buy |
6,469
+6,269
| +3,135% | +$182K | ﹤0.01% | 5494 |
|
|
2017
Q4 | $5K | Buy |
+200
| New | +$5K | ﹤0.01% | 6332 |
|
|
2017
Q2 | – | Sell |
-100
| Closed | -$2K | – | 6592 |
|
|
2017
Q1 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 6451 |
|